Last edition
News about "Next-Generation vMap Arrhythmia Mapping Technology"
Vektor Medical Secures FDA Clearance for Next-Generation vMap Arrhythmia Mapping Technology
Vektor Medical, a San Diego–headquartered medical technology company focused on advancing arrhythmia diagnosis and treatment, has received US Food and Drug Administration 510(k) clearance for its next-generation vMap technology.
Next-Generation VMap Arrhythmia Mapping Technology | 14/12/2025 | By Darshana | 111
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members